Monashee Investment Management LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Monashee Investment Management LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2022$720,000
+572.9%
100,000
+237.2%
0.27%
+1568.8%
Q1 2021$107,000
+40.8%
29,6520.0%0.02%
+60.0%
Q4 2020$76,000
+1800.0%
29,6520.0%0.01%
+900.0%
Q3 2020$4,00029,6520.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders